Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.1M Sell
201,201
-103,818
-34% -$22.1M 2.89% 19
2025
Q4
$69.8M Sell
305,019
-60,370
-17% -$13.3M 5.5% 6
2025
Q3
$72.4M Buy
365,389
+8,735
+2% +$1.74M 5.9% 3
2025
Q2
$70.5M Buy
356,654
+43,333
+14% +$8.4M 5.67% 5
2025
Q1
$64.2M Buy
313,321
+157,334
+101% +$34.4M 5.65% 5
2024
Q4
$35.8M Sell
155,987
-20,261
-11% -$4.98M 2.69% 20
2024
Q3
$49M Sell
176,248
-23,430
-12% -$6.2M 3.63% 15
2024
Q2
$49.9M Buy
199,678
+76,225
+62% +$19.3M 3.58% 13
2024
Q1
$30.8M Sell
123,453
-9,863
-7% -$2.41M 3.48% 13
2023
Q4
$30.8M Buy
133,316
+33,103
+33% +$7.05M 3.71% 14
2023
Q3
$22M Buy
+100,213
New +$22.4M 2.96% 17

Other funds holding DHR

M.D. Sass LLC's DHR Position: Q1 2026 in Review

M.D. Sass LLC reduced its Danaher (DHR) stake by 34% in Q1 2026, selling an estimated $22.1M and leaving 201,201 shares worth $38.1M. The position accounts for 2.89% of the portfolio, ranked #19.

M.D. Sass LLC first reported a position in DHR in Q3 2023 and has held it in 11 quarters since. The position peaked at $72.4M in Q3 2025. 2,165 funds tracked by Wall St. Rank hold DHR as of Q1 2026.

  • M.D. Sass LLC held 201,201 shares of Danaher worth $38.1M as of Q1 2026.
  • M.D. Sass LLC sold 103,818 Danaher shares in Q1 2026, an estimated $22.1M.
  • Danaher made up 2.89% of M.D. Sass LLC's portfolio in Q1 2026, its #19 holding.
  • M.D. Sass LLC first reported a position in Danaher in Q3 2023 and has held it in 11 quarters since.
  • M.D. Sass LLC's Danaher position peaked at $72.4M in Q3 2025.
  • 2,165 funds tracked by Wall St. Rank held Danaher as of Q1 2026.

Based on M.D. Sass LLC's 13F filing for Q1 2026, filed 14 May 2026.